Download full-text PDF

Source
http://dx.doi.org/10.2337/diab.13.1.44DOI Listing

Publication Analysis

Top Keywords

protamine zinc
4
zinc insulin
4
insulin outcome
4
outcome pregnancy
4
pregnancy normal
4
normal rat
4
protamine
1
insulin
1
outcome
1
pregnancy
1

Similar Publications

Objectives: The aim of this study was to describe signalment, clinicopathological findings, management practices and the occurrence of comorbidities in feline diabetes mellitus (DM) in Germany.

Methods: This was a cross-sectional study using questionnaires and laboratory submissions to a commercial laboratory, Antech Lab Germany, between May 2021 and July 2022. Inclusion criteria were diagnosis of DM by the attending veterinarian and submission of a completed questionnaire besides blood samples.

View Article and Find Full Text PDF

Insulin NPH is an intermediate-acting insulin. Its protracted action profile is due to the formation of microcrystalline suspensions when insulin is complexed with a basic peptide protamine, zinc ion, and phenolic ligands. Despite advancements in analytical techniques, the binding epitope and binding mode of the protamine in the insulin-protamine complex are still unknown.

View Article and Find Full Text PDF

Objectives: To evaluate sterility in refrigerated multi-dose insulin vials through 6 months of routine aspiration.

Materials And Methods: Twelve vials of insulin, six of insulin glargine U100 (Lantus®, 10 mL multi-dose vial, Sanofi, Bridgewater, NJ) containing the preservative metacresol, and six of protamine zinc insulin U40 (ProZinc®, 10 mL multi-dose vial, Boehringer Ingelheim, Duluth, GA) containing the preservative phenol, were refrigerated and aspirated twice daily for 6 months, using a new insulin syringe each time. Three vials of each insulin type were wiped with a single-use alcohol swab before sampling.

View Article and Find Full Text PDF

One hundred years of insulin: Is it time for smart?

J Small Anim Pract

September 2022

Animal Diabetes Australia, Melbourne, Victoria, Australia.

Smarter understanding of diabetes pathophysiology and pharmacology of insulin therapy can lead to better clinical outcomes. Rather than looking for an insulin formulation that is considered "best" for a general population, it could be appropriate to seek the "smart" insulin choice, tailored to the specific clinical situation. Different treatment goals should be considered, with pros and cons to each.

View Article and Find Full Text PDF

Background: Drug therapy for diabetes mellitus (DM) has had a significant impact on quality of life and work potential of affected persons and has contributed to a remarkable decrease in the frequency and severity of complications, hospitalizations, and mortality. The current approach is the result of incremental progress in using technological advances to increase the safety and effectiveness of insulin therapy and the introduction of new molecules as oral and injectable antidiabetic drugs.

Study Question: What are the milestones of the changes in the expert approach to the pharmacological management of DM in the past century?

Study Design: To determine the changes in the experts' approach to the management of DM, as presented in a widely used textbook in the United States.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!